Start your intake Clinical trials of semaglutide for weight loss documented nausea, vomiting, diarrhea, and constipation as the most frequent side effects, but sore throat did not appear as a primary adverse event
Most patients report meaningful appetite suppression within the first two weeks, though the exact timing varies based on individual metabolism, starting dose, and genetic factors affecting GLP-1 receptor sensitivity
This distinction is critical: the drug itself is not the problem, but how fast your body adapts to weight loss is the actual concern
The following serious adverse reactions are described below or elsewhere in the prescribing information: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
ALL YOU NEED FOR FACE, BODY & SOUL WE ARE OPEN
You're still eating less than before